Ypsilon Therapeutics
PrivateLast Round
Seed
Nov 20, 2024
Total Funding Raised
$2.73M
Company Overview
Ypsilon Therapeutics operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Seed round in November 2024.
Ypsilon Therapeutics is a biotechnology company developing T-cell receptor mimic (TCRm) antibody and bispecific T-cell engager therapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ypsilon Therapeutics Comparables
Compare Ypsilon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aakha Biologics | 82% | |
| Cantai Therapeutics | 80% | |
| Voro Therapeutics | 78% |
For institutional investors. Book with your work email.
Ypsilon Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ypsilon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 82VS | Seed |
| Cancer Prevention and Research Institute of Texas | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2024
$2.7M round led by CPRIT
For institutional investors. Book with your work email.
Ypsilon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ypsilon Therapeutics's valuation, stock price, and market status.
Is Ypsilon Therapeutics a public or private company?
Ypsilon Therapeutics is a private company.
What is the current stock price of Ypsilon Therapeutics?
Ypsilon Therapeutics is a private company, so its shares have no public market price. Caplight tracks Ypsilon Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ypsilon Therapeutics worth (valuation)?
Valuation information for Ypsilon Therapeutics is not publicly available.
Can I buy Ypsilon Therapeutics stock?
Ypsilon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ypsilon Therapeutics's last funding round?
Ypsilon Therapeutics's most recent funding round was Seed on November 20, 2024.
Who are the main investors in Ypsilon Therapeutics?
Key investors in Ypsilon Therapeutics include Cancer Prevention and Research Institute of Texas.
Will Ypsilon Therapeutics IPO soon?
No public IPO plans have been announced for Ypsilon Therapeutics.
How can I track Ypsilon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Ypsilon Therapeutics's shares on secondary markets.